
Last update at 2026-06-03T20:19:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Is Dentsply Sirona (XRAY) Stock Undervalued Right Now?
Wed 14 May 25, 01:40 PMHere's Why Dentsply International (XRAY) is a Strong Value Stock
Wed 14 May 25, 01:40 PMDentsply (XRAY) Reliance on International Sales: What Investors Need to Know
Tue 13 May 25, 01:16 PMDENTSPLY SIRONA First Quarter 2025 Earnings: Beats Expectations
Sat 10 May 25, 02:18 PMDentsply Sirona Inc (XRAY) Q1 2025 Earnings Call Highlights: Navigating Challenges with ...
Fri 09 May 25, 07:14 AMQ1 2025 DENTSPLY SIRONA Inc Earnings Call
Fri 09 May 25, 04:56 AMWhy Dentsply Sirona Inc. (XRAY) Went Up On Thursday
Fri 09 May 25, 04:43 AMXRAY Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down
Thu 08 May 25, 03:53 PM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | -1055.00000M | 559.00M | -60.00000M | 345.40M | -958.40000M |
| Minority interest | 0.00000M | 0.00000M | 3.00M | 0.20M | 0.10M |
| Net income | -950.00000M | 421.00M | -83.00000M | 262.90M | -1011.00000M |
| Selling general administrative | 1589.00M | 1551.00M | 1435.00M | 1723.50M | 1719.10M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 2127.00M | 2361.00M | 1657.00M | 2165.10M | 2067.80M |
| Reconciled depreciation | 328.00M | 346.00M | 334.00M | 322.80M | 330.80M |
| Ebit | 306.00M | 622.00M | 456.00M | 522.30M | 1655.50M |
| Ebitda | 634.00M | 1002.00M | 790.00M | 845.10M | 1986.30M |
| Depreciation and amortization | 328.00M | 380.00M | 334.00M | 322.80M | 330.80M |
| Non operating income net other | -58.00000M | -8.00000M | - | 13.90M | 37.00M |
| Operating income | 306.00M | 622.00M | 456.00M | 522.30M | -958.10000M |
| Other operating expenses | 3558.00M | 3612.00M | 3120.00M | 3587.60M | 3637.60M |
| Interest expense | 60.00M | 55.00M | 48.00M | 29.40M | 37.30M |
| Tax provision | -105.00000M | 138.00M | 23.00M | 82.30M | 52.50M |
| Interest income | - | - | 1.00M | 2.40M | 2.10M |
| Net interest income | -60.00000M | -55.00000M | -48.00000M | -27.00000M | -35.20000M |
| Extraordinary items | - | - | - | - | 4.10M |
| Non recurring | 1301.00M | 17.00M | 234.00M | -80.70000M | 1306.80M |
| Other items | - | - | - | - | - |
| Income tax expense | -105.00000M | 138.00M | 23.00M | 82.30M | 52.50M |
| Total revenue | 3922.00M | 4251.00M | 3342.00M | 4029.20M | 3986.30M |
| Total operating expenses | 1763.00M | 1722.00M | 1435.00M | 1723.50M | 1719.10M |
| Cost of revenue | 1795.00M | 1890.00M | 1685.00M | 1864.10M | 1918.50M |
| Total other income expense net | -1361.00000M | -63.00000M | -516.00000M | -176.90000M | -1306.80000M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | -950.00000M | 421.00M | -83.00000M | 263.10M | -1010.90000M |
| Net income applicable to common shares | -950.00000M | 421.00M | -83.00000M | 262.90M | -1011.00000M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 7370.00M | 7643.00M | 9220.00M | 9342.00M | 8602.90M |
| Intangible assets | 1705.00M | 1903.00M | 2319.00M | 2504.00M | 2176.30M |
| Earning assets | - | - | - | - | - |
| Other current assets | 259.00M | 269.00M | 83.00M | 66.00M | 100.70M |
| Total liab | 4076.00M | 3831.00M | 4177.00M | 4372.00M | 3508.00M |
| Total stockholder equity | 3293.00M | 3812.00M | 5043.00M | 4970.00M | 5094.90M |
| Deferred long term liab | - | - | 14.00M | - | - |
| Other current liab | 651.00M | 689.00M | 685.00M | 672.00M | 656.10M |
| Common stock | 3.00M | 3.00M | 3.00M | 3.00M | 2.60M |
| Capital stock | 3.00M | 3.00M | 3.00M | 3.00M | 2.60M |
| Retained earnings | 205.00M | 456.00M | 1560.00M | 1233.00M | 1404.20M |
| Other liab | - | 661.00M | 933.00M | 947.00M | 949.10M |
| Good will | 2438.00M | 2688.00M | 3976.00M | 3986.00M | 3396.50M |
| Other assets | - | 198.00M | 122.00M | 270.00M | 68.50M |
| Cash | 334.00M | 365.00M | 339.00M | 438.00M | 404.90M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 1425.00M | 1170.00M | 1186.00M | 1317.00M | 995.50M |
| Current deferred revenue | 91.00M | 84.00M | 51.00M | 41.00M | 29.20M |
| Net debt | 1965.00M | 1728.00M | 1901.00M | 1969.00M | 1150.00M |
| Short term debt | 378.00M | 118.00M | 182.00M | 299.00M | 2.30M |
| Short long term debt | 322.00M | 118.00M | 182.00M | 299.00M | 2.30M |
| Short long term debt total | 2299.00M | 2093.00M | 2240.00M | 2407.00M | 1554.90M |
| Other stockholder equity | 3721.00M | 3981.00M | 4072.00M | 4198.00M | 4287.80M |
| Property plant equipment | - | 961.00M | 966.00M | 791.00M | 802.40M |
| Total current assets | 1973.00M | 1893.00M | 1837.00M | 1791.00M | 1999.90M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | - | -780.00000M | -1252.00000M | -1523.00000M | -480.30000M |
| Short term investments | 33.00M | - | - | - | 40.40M |
| Net receivables | 756.00M | 632.00M | 747.00M | 673.00M | 782.00M |
| Long term debt | 1796.00M | 1826.00M | 1913.00M | 1978.00M | 1433.10M |
| Inventory | 624.00M | 627.00M | 504.00M | 466.00M | 561.70M |
| Accounts payable | 305.00M | 279.00M | 268.00M | 305.00M | 307.90M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | 1.00M | 1.00M | 3.00M | 2.40M |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -636.00000M | -628.00000M | -592.00000M | -464.00000M | -599.70000M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | 3.00M | 3.00M | 3.00M | 2.60M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | 456.00M | 1560.00M | 1233.00M | 1404.20M |
| Treasury stock | - | - | -2535.00000M | -2409.00000M | -2301.30000M |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 59.00M | -89.00000M | 122.00M | 94.00M | 68.50M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 5397.00M | 5750.00M | 7383.00M | 7551.00M | 6603.00M |
| Capital lease obligations | 181.00M | 149.00M | 195.00M | 130.00M | 163.20M |
| Long term debt total | - | - | - | - | 1433.10M |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Investments | -98.00000M | -138.00000M | -358.00000M | 57.00M | 41.30M |
| Change to liabilities | - | 10.00M | -46.00000M | -94.00000M | 53.40M |
| Total cashflows from investing activities | - | -138.00000M | -358.00000M | -1106.00000M | -68.40000M |
| Net borrowings | - | -66.00000M | -102.00000M | -705.00000M | -319.70000M |
| Total cash from financing activities | -307.00000M | -329.00000M | -379.00000M | 490.00M | -466.10000M |
| Change to operating activities | - | -37.00000M | 43.00M | 11.00M | 47.60M |
| Net income | -132.00000M | -950.00000M | 421.00M | -83.00000M | 263.10M |
| Change in cash | -31.00000M | 26.00M | -99.00000M | 33.00M | 95.30M |
| Begin period cash flow | 365.00M | 339.00M | 438.00M | 405.00M | 309.60M |
| End period cash flow | 334.00M | 365.00M | 339.00M | 438.00M | 404.90M |
| Total cash from operating activities | 377.00M | 517.00M | 657.00M | 635.00M | 632.80M |
| Issuance of capital stock | - | - | - | - | - |
| Depreciation | 343.00M | 328.00M | 346.00M | 334.00M | 322.80M |
| Other cashflows from investing activities | - | -2.00000M | 4.00M | -1076.00000M | 13.20M |
| Dividends paid | 116.00M | 104.00M | 92.00M | 88.00M | 80.90M |
| Change to inventory | 6.00M | -141.00000M | -63.00000M | 124.00M | 13.70M |
| Change to account receivables | -58.00000M | 85.00M | -109.00000M | 126.00M | -91.40000M |
| Sale purchase of stock | -300.00000M | -150.00000M | -200.00000M | -140.00000M | -260.00000M |
| Other cashflows from financing activities | -10.00000M | -73.00000M | -36.00000M | -42.00000M | -33.20000M |
| Change to netincome | - | 1217.00M | 48.00M | 170.00M | 56.60M |
| Capital expenditures | 149.00M | 149.00M | 142.00M | 87.00M | 122.90M |
| Change receivables | - | 85.00M | -109.00000M | 126.00M | -91.40000M |
| Cash flows other operating | - | -32.00000M | -45.00000M | 53.00M | 11.90M |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | 50.00M | -80.00000M | 19.00M | 98.30M |
| Change in working capital | -89.00000M | -78.00000M | -158.00000M | 199.00M | -19.80000M |
| Stock based compensation | 46.00M | 59.00M | 48.00M | 47.00M | 66.20M |
| Other non cash items | 339.00M | 1386.00M | 20.00M | 202.00M | 37.90M |
| Free cash flow | 228.00M | 368.00M | 515.00M | 548.00M | 509.90M |
Sector: Healthcare Industry: Medical Instruments & Supplies
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| XRAY Dentsply Sirona Inc |
-0.19 1.93% | 9.64 | - | 15.27 | 1.64 | 1.97 | 2.13 | 33.99 |
| ISRG Intuitive Surgical Inc |
4.99 1.24% | 407.29 | 73.05 | 61.73 | 19.15 | 10.25 | 18.41 | 59.92 |
| ESLOF EssilorLuxottica Société anonyme |
- -% | 196.12 | 44.84 | 27.62 | 4.07 | 2.49 | 3.71 | 16.04 |
| ESLOY Essilor International SA |
-0.98 0.99% | 98.17 | 41.68 | 27.25 | 3.94 | 2.45 | 3.71 | 16.04 |
| BDX Becton Dickinson and Company |
1.18 0.82% | 145.61 | 25.56 | 12.48 | 2.59 | 1.76 | 2.89 | 12.55 |
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform. It also provides endodontic products consisting of motorized endodontic handpieces, files, sealers, irrigation needles, and other tools that support root canal procedures; restorative products, including dental ceramics, crowns, and veneers; and preventative products, such as curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, and impression materials. In addition, the company offers SureSmile and Byte aligner solutions; VPro/HyperByte, a high-frequency vibration technology device; SureSmile Simulator, which creates a 3D visualization of a patient's outcome; and Byte Plus for treatment planning. Further, it provides dental implants, digital dentures, crown and bridge porcelain products, bone regenerative and restorative solutions, treatment planning software, and educational programs; dental prosthetics; urology catheters; and other health-related consumables. The company serves professional dental and consumable medical device markets through third-party distributors. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina
13320-B Ballantyne Corporate Place, Charlotte, NC, United States, 28277-3607
| Name | Title | Year Born |
|---|---|---|
| Mr. Simon D. Campion | CEO, Pres & Director | 1971 |
| Mr. Glenn G. Coleman | Exec. VP & CFO | 1968 |
| Mr. Richard M. Wagner | Chief Accounting Officer & Principal Accounting Officer | 1968 |
| Mr. Cord Friedrich Staehler | Sr. VP of Digital Platforms & Solutions and CTO | 1970 |
| Andrea Daley | VP of Investor Relations | NA |
| Ms. Cheree Haswell Johnson | Sr. VP, Chief Legal Officer, Gen. Counsel & Sec. | 1976 |
| Ms. Erania Brackett | Sr. VP & Chief Marketing Officer | NA |
| Ms. Lisa M. Yankie | Sr. VP & Chief HR Officer | 1969 |
| Mr. Andrew Robinson | Sr. VP of North American Commercial Leader & Chief Digital Officer | NA |
| Mr. Andreas G. Frank | Exec. VP of Product Group | 1976 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.